{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:10:30Z","timestamp":1767856230675,"version":"3.49.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/33\/B\/NZ7\/02872"],"award-info":[{"award-number":["2019\/33\/B\/NZ7\/02872"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-72814-0","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:05:01Z","timestamp":1726495501000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"Edyta","family":"Paradowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daria A.","family":"Har\u0119\u017ca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna D.","family":"Kania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Jarych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi\u0142osz","family":"Wilczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kawecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateusz","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek R.","family":"Wilczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"72814_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"72814_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin.73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"72814_CR3","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1038\/s41598-021-84953-9","volume":"11","author":"DVNP Oliveira","year":"2021","unstructured":"Oliveira, D. V. N. P. et al. Gene expression profile association with poor prognosis in epithelial ovarian cancer patients. Sci. Rep.11, 5438 (2021).","journal-title":"Sci. Rep."},{"key":"72814_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","volume":"43","author":"WG McCluggage","year":"2011","unstructured":"McCluggage, W. G. Morphological subtypes of ovarian carcinoma: A review with emphasis on new developments and pathogenesis. Pathology43, 420\u2013432 (2011).","journal-title":"Pathology"},{"key":"72814_CR5","doi-asserted-by":"crossref","unstructured":"Kurman, R. J. & Shih, I. M. Pathogenesis of ovarian Cancer: Lessons from morphology and Molecular Biology and their clinical implications. Int. J. Gynecol. Pathol. PAP (2008).","DOI":"10.1097\/PGP.0b013e318161e4f5"},{"key":"72814_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","volume":"43","author":"M Yousefi","year":"2020","unstructured":"Yousefi, M. et al. Current insights into the metastasis of epithelial ovarian cancer\u2014Hopes and hurdles. Cell. Oncol.43, 515\u2013538 (2020).","journal-title":"Cell. Oncol."},{"key":"72814_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41467-020-15089-z","volume":"11","author":"EK Colvin","year":"2020","unstructured":"Colvin, E. K. & Howell, V. M. Why the dual origins of high grade serous ovarian cancer matter. Nat. Commun.11, 1200 (2020).","journal-title":"Nat. Commun."},{"key":"72814_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","volume":"27","author":"E Jarboe","year":"2008","unstructured":"Jarboe, E. et al. Serous carcinogenesis in the fallopian tube: A descriptive classification. Int. J. Gynecol. Pathol.27, 1\u20139 (2008).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"72814_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun.8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"72814_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","volume":"39","author":"CB Gilks","year":"2015","unstructured":"Gilks, C. B. et al. Incidental Nonuterine High-grade Serous carcinomas arise in the fallopian tube in most cases: Further evidence for the Tubal origin of high-grade Serous Carcinomas. Am. J. Surg. Pathol.39, 357\u2013364 (2015).","journal-title":"Am. J. Surg. Pathol."},{"key":"72814_CR11","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1038\/s41467-019-13116-2","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nat. Commun.10, 5367 (2019).","journal-title":"Nat. Commun."},{"key":"72814_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"72814_CR13","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast Cancer for BRCA1 and BRCA2 mutation carriers. JAMA317, 2402 (2017).","journal-title":"JAMA"},{"key":"72814_CR14","doi-asserted-by":"publisher","first-page":"2300166","DOI":"10.1002\/bies.202300166","volume":"46","author":"A Uboveja","year":"2024","unstructured":"Uboveja, A. & Aird, K. M. Interplay between altered metabolism and DNA damage and repair in ovarian cancer. BioEssays46, 2300166 (2024).","journal-title":"BioEssays"},{"key":"72814_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb, P. M. & Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol.21, 389\u2013400 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"72814_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S1470-2045(19)30340-7","volume":"20","author":"NR Nen\u00e9","year":"2019","unstructured":"Nen\u00e9, N. R. et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: A case-control study. Lancet Oncol.20, 1171\u20131182 (2019).","journal-title":"Lancet Oncol."},{"key":"72814_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ijc.31027","volume":"142","author":"A Steinbach","year":"2018","unstructured":"Steinbach, A. & Riemer, A. B. Immune evasion mechanisms of human papillomavirus: An update. Int. J. Cancer142, 224\u2013229 (2018).","journal-title":"Int. J. Cancer"},{"key":"72814_CR18","first-page":"1","volume":"2018","author":"X Wang","year":"2018","unstructured":"Wang, X., Zeng, Y., Huang, X. & Zhang, Y. Prevalence and genotype distribution of human papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic women in Southeast China. Biomed. Res. Int.2018, 1\u201310 (2018).","journal-title":"Biomed. Res. Int."},{"key":"72814_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1158\/1055-9965.EPI-12-0953-T","volume":"22","author":"K Sundstr\u00f6m","year":"2013","unstructured":"Sundstr\u00f6m, K. et al. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cervical Cancer. Cancer Epidemiol. Biomarkers Prev.22, 150\u2013158 (2013).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"72814_CR20","first-page":"121","volume":"36","author":"OO Bilyk","year":"2014","unstructured":"Bilyk, O. O., Pande, N. T., Pejovic, T. & Buchinska, L. G. The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer. Exp. Oncol.36, 121\u2013124 (2014).","journal-title":"Exp. Oncol."},{"key":"72814_CR21","doi-asserted-by":"publisher","first-page":"19935","DOI":"10.1038\/s41598-019-56448-1","volume":"9","author":"E Paradowska","year":"2019","unstructured":"Paradowska, E., Jab\u0142o\u0144ska, A., Studzi\u0144ska, M., Wilczy\u0144ski, M. & Wilczy\u0144ski, J. R. Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients. Sci. Rep.9, 19935 (2019).","journal-title":"Sci. Rep."},{"key":"72814_CR22","first-page":"642","volume":"26","author":"E Kuscu","year":"2005","unstructured":"Kuscu, E., Ozdemir, B. H., Erkanli, S. & Haberal, A. HPV and p53 expression in epithelial ovarian carcinoma. Eur. J. Gynaecol. Oncol.26, 642\u2013645 (2005).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"72814_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1447-0756.2007.00663.x","volume":"33","author":"F Atalay","year":"2007","unstructured":"Atalay, F. et al. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J. Obstet. Gynaecol. Res.33, 823\u2013828 (2007).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"72814_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1743-422X-10-343","volume":"10","author":"OA Al-Shabanah","year":"2013","unstructured":"Al-Shabanah, O. A. et al. Human papillomavirus genotyping and integration in ovarian cancer Saudi patients. Virol. J.10, 343 (2013).","journal-title":"Virol. J."},{"key":"72814_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/00004347-199207000-00007","volume":"11","author":"CH Lai","year":"1992","unstructured":"Lai, C. H. et al. Human papillomavirus in Benign and malignant ovarian and endometrial tissues. Int. J. Gynecol. Pathol.11, 210\u2013215 (1992).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"72814_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/sj.bjc.6601172","volume":"89","author":"QJ Wu","year":"2003","unstructured":"Wu, Q. J. et al. Detection of human papillomavirus-16 in ovarian malignancy. Br. J. Cancer89, 672\u2013675 (2003).","journal-title":"Br. J. Cancer"},{"key":"72814_CR27","unstructured":"Hassan, Z., Hafez, M. M., Kamel, M. M. & Zekri, N. A. R. Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients. APJCP18 (2017)."},{"key":"72814_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00404-012-2367-6","volume":"286","author":"E Malisic","year":"2012","unstructured":"Malisic, E., Jankovic, R. & Jakovljevic, K. Detection and genotyping of human papillomaviruses and their role in the development of ovarian carcinomas. Arch. Gynecol. Obstet.286, 723\u2013728 (2012).","journal-title":"Arch. Gynecol. Obstet."},{"key":"72814_CR29","doi-asserted-by":"crossref","unstructured":"Dadashi, M. et al. Detection of human papilloma virus type 16 in epithelial ovarian tumors samples. Arch. Clin. Infect. Dis.12, (2016).","DOI":"10.5812\/archcid.39666"},{"key":"72814_CR30","first-page":"2959","volume":"17","author":"PP Zhang","year":"2016","unstructured":"Zhang, P. P. et al. Possible epithelial ovarian cancer association with HPV18 or HPV33 infection. Asian Pac. J. Cancer Prev.17, 2959\u20132964 (2016).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"72814_CR31","doi-asserted-by":"publisher","first-page":"8645","DOI":"10.1038\/srep08645","volume":"5","author":"P Roos","year":"2015","unstructured":"Roos, P., Orlando, P. A., Fagerstrom, R. M. & Pepper, J. W. In North America, some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18. Sci. Rep.5, 8645 (2015).","journal-title":"Sci. Rep."},{"key":"72814_CR32","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s10096-021-04282-7","volume":"40","author":"S Cherif","year":"2021","unstructured":"Cherif, S. et al. Prevalence of human papillomavirus detection in ovarian cancer: A meta-analysis. Eur. J. Clin. Microbiol. Infect. Dis.40, 1791\u20131802 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"72814_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/cancers12030561","volume":"12","author":"S Pathak","year":"2020","unstructured":"Pathak, S., Wilczy\u0144ski, J. R. & Paradowska, E. Factors in Oncogenesis: Viral infections in Ovarian Cancer. Cancers12, 561 (2020).","journal-title":"Cancers"},{"key":"72814_CR34","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.3390\/ijms23031818","volume":"23","author":"DA Har\u0119\u017ca","year":"2022","unstructured":"Har\u0119\u017ca, D. A., Wilczy\u0144ski, J. R. & Paradowska, E. Human papillomaviruses as Infectious agents in Gynecological cancers. Oncogenic properties of viral proteins. IJMS23, 1818 (2022).","journal-title":"IJMS"},{"key":"72814_CR35","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","volume":"31","author":"S Shanmughapriya","year":"2012","unstructured":"Shanmughapriya, S. et al. Viral and bacterial aetiologies of epithelial ovarian cancer. Eur. J. Clin. Microbiol. Infect. Dis.31, 2311\u20132317 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"72814_CR36","doi-asserted-by":"publisher","first-page":"71e1","DOI":"10.1016\/j.ajog.2009.07.042","volume":"202","author":"A Idahl","year":"2010","unstructured":"Idahl, A. et al. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am. J. Obstet. Gynecol.202, 71e1\u201371e6 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"72814_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13027-016-0087-4","volume":"11","author":"K Ingerslev","year":"2016","unstructured":"Ingerslev, K. et al. High-risk HPV is not associated with epithelial ovarian cancer in a caucasian population. Infect. Agents Cancer11, 39 (2016).","journal-title":"Infect. Agents Cancer"},{"key":"72814_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/gyno.1998.5264","volume":"72","author":"M Anttila","year":"1999","unstructured":"Anttila, M., Syrj\u00e4nen, S., Ji, H., Saarikoski, S. & Syrj\u00e4nen, K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian Cancer by general primer PCR. Gynecol. Oncol.72, 337\u2013341 (1999).","journal-title":"Gynecol. Oncol."},{"key":"72814_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13027-019-0223-z","volume":"14","author":"K Ingerslev","year":"2019","unstructured":"Ingerslev, K. et al. The prevalence of EBV and CMV DNA in epithelial ovarian cancer. Infect. Agents Cancer14, 7 (2019).","journal-title":"Infect. Agents Cancer"},{"key":"72814_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3390\/pathogens12030397","volume":"12","author":"BO Grabarek","year":"2023","unstructured":"Grabarek, B. O. et al. Detection and genotyping of human papillomavirus (HPV16\/18), Epstein\u2013Barr Virus (EBV), and human cytomegalovirus (HCMV) in endometrial endometroid and ovarian cancers. Pathogens12, 397 (2023).","journal-title":"Pathogens"},{"key":"72814_CR41","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.tranon.2018.08.003","volume":"11","author":"AF R\u00e5destad","year":"2018","unstructured":"R\u00e5destad, A. F. et al. Impact of human cytomegalovirus infection and its Immune response on survival of patients with ovarian Cancer. Transl. Oncol.11, 1292\u20131300 (2018).","journal-title":"Transl. Oncol."},{"key":"72814_CR42","doi-asserted-by":"publisher","first-page":"e9685","DOI":"10.1097\/MD.0000000000009685","volume":"97","author":"JW Carlson","year":"2018","unstructured":"Carlson, J. W., R\u00e5destad, A. F., S\u00f6derberg-Naucler, C. & Rahbar, A. Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival. Medicine97, e9685 (2018).","journal-title":"Medicine"},{"key":"72814_CR43","doi-asserted-by":"publisher","first-page":"104505","DOI":"10.1016\/j.jcv.2020.104505","volume":"129","author":"A Stevenson","year":"2020","unstructured":"Stevenson, A. et al. Droplet digital PCR quantification suggests that higher viral load correlates with improved survival in HPV-positive oropharyngeal tumours. J. Clin. Virol.129, 104505 (2020).","journal-title":"J. Clin. Virol."},{"key":"72814_CR44","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1128\/JVI.03434-14","volume":"89","author":"M McFarlane","year":"2015","unstructured":"McFarlane, M., MacDonald, A. I., Stevenson, A. & Graham, S. V. Human papillomavirus 16 Oncoprotein expression is controlled by the Cellular splicing factor SRSF2 (SC35). J. Virol.89, 5276\u20135287 (2015).","journal-title":"J. Virol."},{"key":"72814_CR45","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1093\/annonc\/mdy251","volume":"29","author":"GJ Hanna","year":"2018","unstructured":"Hanna, G. J. et al. Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer. Ann. Oncol.29, 1980\u20131986 (2018).","journal-title":"Ann. Oncol."},{"key":"72814_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/microorganisms7120628","volume":"7","author":"T Shuto","year":"2019","unstructured":"Shuto, T. et al. Establishment of a screening method for Epstein\u2013Barr Virus-Associated gastric carcinoma by Droplet Digital PCR. Microorganisms7, 628 (2019).","journal-title":"Microorganisms"},{"key":"72814_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jmv.1048","volume":"64","author":"AF Hassan-Walker","year":"2001","unstructured":"Hassan-Walker, A. F., Mattes, F. M., Griffiths, P. D. & Emery, V. C. Quantity of cytomegalovirus DNA in different leukocyte populations during active infection in vivo and the presence of gB and UL18 transcripts. J. Med. Virol.64, 283\u2013289 (2001).","journal-title":"J. Med. Virol."},{"key":"72814_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1600-0463.2006.apm_31.x","volume":"114","author":"E Paradowska","year":"2006","unstructured":"Paradowska, E. et al. Detection of cytomegalovirus in human placental cells by polymerase chain reaction. Apmis114, 764\u2013771 (2006).","journal-title":"Apmis"},{"key":"72814_CR49","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.3390\/ijms20215482","volume":"20","author":"M Nakamura","year":"2019","unstructured":"Nakamura, M., Obata, T., Daikoku, T. & Fujiwara, H. The Association and significance of p53 in gynecologic cancers: The potential of targeted therapy. IJMS20, 5482 (2019).","journal-title":"IJMS"},{"key":"72814_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-0-387-68969-2_9","volume-title":"Ovarian Cancer","author":"DC Corney","year":"2008","unstructured":"Corney, D. C., Flesken-Nikitin, A., Choi, J. & Nikitin, A. Y. Role of p53 and rb in Ovarian Cancer. In Ovarian Cancer, Vol. 622 (eds Coukos, G., Berchuck, A. & Ozols, R.)  99\u2013117 (Springer New York, New York, 2008)."},{"key":"72814_CR51","doi-asserted-by":"publisher","first-page":"591452","DOI":"10.3389\/fmicb.2020.591452","volume":"11","author":"JC Rotondo","year":"2020","unstructured":"Rotondo, J. C. et al. Simultaneous detection and viral DNA load quantification of different human papillomavirus types in clinical specimens by the high analytical droplet digital PCR method. Front. Microbiol.11, 591452 (2020).","journal-title":"Front. Microbiol."},{"key":"72814_CR52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/IGC.0b013e318280f3e0","volume":"23","author":"MI Rosa","year":"2013","unstructured":"Rosa, M. I. et al. The prevalence of human papillomavirus in ovarian Cancer: A systematic review. Int. J. Gynecol. Cancer23, 437\u2013441 (2013).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"72814_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/aogs.12254","volume":"93","author":"MF Svahn","year":"2014","unstructured":"Svahn, M. F., Faber, M. T., Christensen, J., Norrild, B. & Kjaer, S. K. Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies. Acta Obstet. Gynecol. Scand.93, 6\u201319 (2014).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"72814_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13027-020-00289-5","volume":"15","author":"M Yin","year":"2020","unstructured":"Yin, M. et al. Detection of human cytomegalovirus in patients with epithelial ovarian cancer and its impacts on survival. Infect. Agents Cancer15, 23 (2020).","journal-title":"Infect. Agents Cancer"},{"key":"72814_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s12885-023-11566-y","volume":"23","author":"RI Vogel","year":"2023","unstructured":"Vogel, R. I. et al. Prevalence of active cytomegalovirus infection at diagnosis of ovarian cancer and during chemotherapy and subsequent changes in cognitive functioning. BMC Cancer23, 1057 (2023).","journal-title":"BMC Cancer"},{"key":"72814_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biomedicines9040351","volume":"9","author":"M Cox","year":"2021","unstructured":"Cox, M., Kartikasari, A. E. R., Gorry, P. R., Flanagan, K. L. & Plebanski, M. Potential impact of human cytomegalovirus infection on immunity to ovarian tumours and cancer progression. Biomedicines9, 351 (2021).","journal-title":"Biomedicines"},{"key":"72814_CR57","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1002\/jmv.26664","volume":"93","author":"A Rahbar","year":"2021","unstructured":"Rahbar, A., Pantalone, M. R., Religa, P. & R\u00e5destad, A. F. S\u00f6derberg-Naucler, C. evidence of human cytomegalovirus infection and expression of 5\u2010lipoxygenase in borderline ovarian tumors. J. Med. Virol.93, 4023\u20134027 (2021).","journal-title":"J. Med. Virol."},{"key":"72814_CR58","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2016.08.318","volume":"143","author":"CB Rasmussen","year":"2016","unstructured":"Rasmussen, C. B., Jensen, A., Albieri, V., Andersen, K. K. & Kjaer, S. K. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Gynecol. Oncol.143, 346\u2013351 (2016).","journal-title":"Gynecol. Oncol."},{"key":"72814_CR59","doi-asserted-by":"publisher","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson, B. J. et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal. Chem.83, 8604\u20138610 (2011).","journal-title":"Anal. Chem."},{"key":"72814_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/jmv.25017","volume":"90","author":"M Okodo","year":"2018","unstructured":"Okodo, M., Okayama, K., Teruya, K. & Sasagawa, T. Uniplex E6\/E7 PCR method detecting E6 or E7 genes in 39 human papillomavirus types. J. Med. Virol.90, 981\u2013988 (2018).","journal-title":"J. Med. Virol."},{"key":"72814_CR61","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10096-011-1447-z","volume":"31","author":"E Paradowska","year":"2012","unstructured":"Paradowska, E. et al. Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections. Eur. J. Clin. Microbiol. Infect. Dis.31, 1335\u20131345 (2012).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"72814_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1746-1596-1-17","volume":"1","author":"R Hassan","year":"2006","unstructured":"Hassan, R. et al. Epstein-Barr Virus (EBV) detection and typing by PCR: A contribution to diagnostic screening of EBV-positive Burkitt\u2019s lymphoma. Diagn. Pathol.1, 17 (2006).","journal-title":"Diagn. Pathol."},{"key":"72814_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-3701-5-3","volume":"5","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro. Cell. Biosci.5, 3 (2015).","journal-title":"Cell. Biosci."},{"key":"72814_CR64","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bdq.2017.09.001","volume":"13","author":"M Van Heetvelde","year":"2017","unstructured":"Van Heetvelde, M. et al. Evaluation of relative quantification of alternatively spliced transcripts using droplet digital PCR. Biomol. Detect. Quantif.13, 40\u201348 (2017).","journal-title":"Biomol. Detect. Quantif."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72814-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72814-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72814-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:18:23Z","timestamp":1726496303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-72814-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["72814"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-72814-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21602"}}